NPPA Fixes Retail Prices of 62 Formulations, Details
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, Government of India, has fixed retail prices for 62 formulations under the Drugs (Prices Control) Order, 2013.
The list of formulations includes Ibuprofen and Paracetamol Suspension, manufactured and marketed by Innova Captab/ Dr. Reddy’s Laboratories, Telmisartan, Amlodipine and Hydrochlorothiazide tablets, manufactured and marketed by Akums Drugs and Pharmaceuticals/Sun Pharmaceutical Industries, Amlodipine, Telmisartan and Metoprolol Succinate (Extended Release) tablets manufactured and marketed by Akums Drugs & Pharmaceutical and others.
This comes after exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), has fixed, the price as specified in column (6) of the Table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit, and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
S. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (in Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1 | Ibuprofen & Paracetamol Suspension | Each 5ml contains: Ibuprofen IP 100 mg, Paracetamol IP 162.5mg | 1 ml | M/s Innova Captab Ltd/ M/s Dr. Reddy’s Laboratories Ltd | 0.50 |
2 | Telmisartan, Amlodipine & Hydrochlorothiazide tablets | Each film coated tablet contains: Telmisartan IP 40mg, Amlodipine Besilate IP eq to Amlodipine 5mg, Hydrochlorothiazide IP 12.5mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd/ M/s Sun Pharmaceutical Industries Ltd | 10.23 |
3 | Telmisartan, Cilnidipine & Chlorthalidone tablets | Each film coated tablet contains: Telmisartan IP 40mg, Cilnidipine IP 10mg, Chlorthalidone IP 12.5mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 14.73 |
4 | Telmisartan, Chlorthalidone & Amlodipine tablets | Each film coated tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg, Amlodipine Besylate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Eris Lifesciences Limited | 10.65 |
5 | Telmisartan, Cilnidipine & Chlorthalidone Tablets | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Cilnidipine IP 10mg, Chlorthalidone IP 12.5 mg | 1 Tablet | M/s Windlas Biotech Ltd. / M/s Emcure Pharmaceuticals Limited | 14.85 |
6 | Amlodipine, Telmisartan and Metoprolol Succinate (Extended Release) tablets | Each film coated bilayered tablet contains: Metoprolol Succinate IP 47.5 mg eq. to Metoprolol Tartrate 50mg (as extended release form), Telmisartan IP 40mg, Amlodipine Besylate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cipla Limited | 13.20 |
7 | Amlodipine, Telmisartan and Metoprolol Succinate (Extended Release) tablets | Each film coated bilayered tablet contains: Metoprolol Succinate IP 47.5 mg eq. to Metoprolol Tartrate 50mg (as extended release form), Telmisartan IP 40mg, Amlodipine Besylate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Akumentis Healthcare Ltd. | 13.20 |
8 | Metoprolol Succinate (ER), Cilnidipine & Telmisartan tablets | Each film coated bilayer tablet contains: Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate 25mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s USV Private Limited | 9.82 |
S. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (in Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
(As Extended release from), Cilnidipine IP 10mg, Telmisartan IP 40mg | |||||
9 | Metoprolol Succinate (ER), Cilnidipine & Telmisartan Tablets | Each film coated bilayer tablet contains: Metoprolol Succinate IP 47.5mg eq. to Metoprolol Tartrate 50mg (As Extended release from), Cilnidipine IP 10mg, Telmisartan IP 40mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s USV Private Limited | 12.50 |
10 | Bisoprolol Fumarate and Telmisartan Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg, Telmisartan IP 40 mg | 1 Tablet | M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 11.21 |
11 | Bisoprolol Fumarate and Telmisartan Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg, Telmisartan IP 40 mg | 1 Tablet | M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 9.65 |
12 | Bisoprolol Fumarate and Telmisartan Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg, Telmisartan IP 40 mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Cipla Limited | 9.65 |
13 | Bisoprolol Fumarate and Telmisartan Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg, Telmisartan IP 40 mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Cipla Limited | 11.21 |
14 | Bisoprolol Fumarate and Telmisartan Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg, Telmisartan IP 40 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Medley Pharmaceuticals Ltd. | 9.65 |
15 | Bisoprolol Fumarate and Telmisartan Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg, Telmisartan IP 40 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Medley Pharmaceuticals Ltd. | 11.21 |
16 | Levofloxacin Infusion IP | Each 100ml Contains: Levofloxacin Hemihydrate IP eq to Levofloxacin 500mg, Sodium Chloride IP 900 mg | 1 ml | M/s Pure and Cure Healthcare Pvt Ltd/ M/s Dr Reddy’s Laboratories Ltd | 1.51 |
17 | Moxifloxacin Eye drops IP | Composition: Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v | 1 ml | M/s Appasamy Ocular Devices Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 27.00 |
18 | Moxifloxacin & Ketorolac Tromethamine Eye drops IP | Composition: Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v Ketorolac Tromethamine IP 0.4% w/v Benzalkoniumchloride Solution 0.01%v/v (as preservative) | 1 ml | M/s Appasamy Ocular Devices Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 25.32 |
19 | Moxifloxacin & Dexamethasone Eye drops | Composition: Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v, Dexamethasone Sodium Phosphate IP eq. to Dexamethasone Phosphate 0.1%w/v | 1 ml | M/s Appasamy Ocular Devices Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 25.04 |
20 | Ofloxacin & Dexamethasone Sodium Phosphate Ophthalmic Solution | Composition: Ofloxacin IP 0.3% w/v, Dexamethasone Sodium Phosphate IP eq. to Dexamethasone Phosphate 0.1%w/v, Benzalkonium Chloride Solution IP 0.02%w/v (as preservative) | 1 ml | M/s Hanuchem Laboratories / M/s Mankind Prime Labs Pvt. Ltd. | 5.24 |
S. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (in Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
21 | Chloramphenicol & Dexamethasone Sodium Phosphate Eye/Ear drops | Composition: Chloramphenicol IP 1%w/v, Dexamethasone Sodium Phosphate IP 0.1%w/v, Phenyl Mercuric Nitrate Ip 0.002%w/v (as preservative) | 1 ml | M/s Hanuchem Laboratories / M/s Mankind Prime Labs Pvt. Ltd. | 5.88 |
22 | Tobramycin & Dexamethasone Ophthalmic Solution | Composition: Tobramycin Sulfate USP eq to Tobramycin 0.3%w/v, Dexamethasone Sodium Phosphate IP eq to Dexamethasone Phosphate 0.1%w/v, Benzalkonium Chloride Solution IP 0.02%v/v (as preservative) | 1 ml | M/s Hanuchem Laboratories / M/s Mankind Prime Labs Pvt. Ltd. | 5.78 |
23 | Aceclofenac, Paracetamol & Serratiopeptidase Tablets | Each film coated tablet contains: Aceclofenac IP 100mg, Paracetamol IP 325mg, Serratiopeptidase IP 15mg (As enteric coated tablet eq. to enzyme activity 30000 units) | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 9.74 |
24 | Mefenamic Acid and Paracetamol Tablets | Each uncoated tablet contains: Mefenamic Acid IP 250mg Paracetamol IP 325mg | 1 Tablet | M/s Blue Cross Laboratories Pvt. Ltd. | 3.82 |
25 | Paracetamol and Mefenamic Acid suspension | Each 5ml contains: Mefenamic Acid 100mg, Paracetamol IP 250mg | 1 ml | M/s Windlas Biotech Limited / M/s Biological E. Limited | 0.90 |
26 | Diclofenac Sodium Injection IP | Each ml contains: Diclofenac Sodium IP 75mg | 1 ml | M/s Fast Pharma Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd. | 28.70 |
27 | Lactulose Enema 20% w/v | Each ml contains: Lactulose Concentrate USP eq. to Lactulose 200mg, Benzyl Alcohol IP 3mg | 1 ml | M/s Merril Pharma Private Ltd. / M/s Alkem Laboratories Ltd. | 1.19 |
28 | Cefadroxil and Clavulanic Acid dispersible Tablets | Each uncoated dispersible tablet contains: Cefadroxil Monohydrate IP eq. to Cefadroxil 250mg, Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 62.5mg | 1 Tablet | M/s Twenty First Century Pharmaceuticals Pvt. Ltd. / M/s Indoco Remedies Limited | 9.30 |
29 | Cefadroxil and Clavulanic Acid Tablets | Each film coated tablet contains: Cefadroxil Monohydrate IP eq. to Cefadroxil 500mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125mg | 1 Tablet | M/s Twenty First Century Pharmaceuticals Pvt. Ltd. / M/s Indoco Remedies Limited | 17.61 |
30 | Ferrous Ascorbate and Folic Acid Suspension IP | Each 5ml contains: Ferrous Ascorbate IP eq. to Elemental Iron 30mg Folic Acid IP 550mcg | 1 ml | M/s Tirupati Medicare Ltd. / M/s Intas Pharmaceuticals Ltd. | 0.95 |
31 | Combi pack of Clarithromycin Tablets IP, Esomeprazole Tablets IP & Amoxicillin Tablets USP | Each Strip contains:
Each film coated tablet contains: Clarithromycin IP 500mg
Each Enteric coated tablet contains: Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mg
Tablets | Combi kit pack | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Mankind Pharma Limited | 166.74 |
S. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (in Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Each Film coated tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 750mg | |||||
32 | Etoricoxib and Paracetamol Tablets | Each Film Coated tablet contains: Etoricoxib IP 60 mg (As Micronized), Paracetamol IP 325 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Pharmed Limited | 9.15 |
33 | Etoricoxib and Paracetamol Tablets | Each film coated Tablet contains: Etoricoxib IP 60mg (As micronized) Paracetamol IP 325mg | 1 Tablet | M/s Synokem Lifesciences Pvt. Ltd. / M/s Cipla Ltd. | 9.15 |
34 | Levosalbutamol & Ipratropium Bromide respirator solution | Each 2.5 ml contains: Levosalbutamol Sulphate eq. to Levosalbutamol 1.25 mg + Ipratropium Bromide eq. to Ipratropium (Anhydrous) 500 mcg | 1 ml | M/s Axa Parenterals Limited / M/s Workcell Solutions Private Limited | 5.75 |
35 | Povidone Iodine Gargle | Composition: Povidone-Iodine IP 2% w/v (Available Iodine 0.2% w/v) Ethanol 95% IP eq. to Absolute Alcohol 8.38% v/v | 1 ml | M/s Pontika Aerotech Limited / M/s Abbott Healthcare Pvt. Ltd. | 1.96 |
36 | Omeprazole & Domperidone Capsules IP | Each hard gelatin capsule contains: Omeprazole IP 20mg (as Enteric coated), Domperidone IP 10mg (As Instant release) | 1 Capsule | M/s Hetero Healthcare Ltd. | 6.28 |
37 | Tolperisone Hydrochloride and Paracetamol Tablets | Each film coated tablet contains: Tolperisone Hydrochloride IP 150mg, Paracetamol IP 325mg | 1 Tablet | M/s Pure and cure Healthcare Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd. | 13.95 |
38 | Escitalopram Tablets | Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 15mg | 1 Tablet | M/s East African (India) Overseas / M/s Torrent Pharmaceuticals Ltd. | 13.00 |
39 | Escitalopram Oxalate + Clonazepam Tablets | Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 5mg, Clonazepam IP 0.25mg | 1 Tablet | M/s East African (India) Overseas / M/s Torrent Pharmaceuticals Ltd. | 7.74 |
40 | Escitalopram Oxalate + Clonazepam Tablets | Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 20mg, Clonazepam IP 0.5mg | 1 Tablet | M/s East African (India) Overseas / M/s Torrent Pharmaceuticals Ltd. | 19.67 |
41 | Atorvastatin and Aspirin Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg, Aspirin IP 150mg (As two enteric coated tablet USP 75mg) | 1 Capsule | M/s Unison Pharmaceuticals Pvt. Ltd. | 2.54 |
42 | Riboflavin, Folic Acid Niacinamide & Lactic Acid Bacillus Tablets | Each uncoated tablet contains: Riboflavin IP 10mg, Folic Acid IP 1.5mg, Niacinamide IP 100mg, Lactic Acid Bacillus 60Million Spores | 1 Tablet | M/s Prosperity Drugs Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd. | 4.11 |
43 | Empagliflozin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5mg, Metformin Hydrochloride IP | 1 Tablet | M/s Mankind Pharma Limited | 15.84 |
S. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (in Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
500mg | |||||
44 | Empagliflozin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg, Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Mankind Pharma Limited | 19.01 |
45 | Empagliflozin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg, Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Mankind Pharma Limited | 18.10 |
46 | Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets | Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg, Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 1000mg (as Sustained Release Form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd. | 15.32 |
47 | Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets | Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg, Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 500mg (as Sustained Release Form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Sun Pharma Laboratories Limited | 14.00 |
48 | Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets | Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg, Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 1000mg (as Sustained Release Form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Sun Pharma Laboratories Limited | 15.32 |
49 | Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets | Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg, Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 500mg (as Sustained Release Form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Micro Labs Limited | 14.00 |
50 | Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets | Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg, Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 1000mg (as Sustained Release Form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Micro Labs Limited | 15.32 |
51 | Sitagliptin, Metformin Hydrochloride and Glimepiride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Apex Laboratories Private Limited | 11.60 |
S. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (in Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
50mg, Metformin Hydrochloride IP 1000mg, Glimepiride IP 1 mg | |||||
52 | Sitagliptin, Metformin Hydrochloride and Glimepiride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg, Metformin Hydrochloride IP 1000mg, Glimepiride IP 2 mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Apex Laboratories Private Limited | 11.60 |
53 | Linagliptin, Dapagliflozin & Metformin Hydrochloride (SR) Tablets | Each film coated bilayer Tablet contains: Linagliptin 5mg, Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg, Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd. | 20.33 |
54 | Linagliptin, Dapagliflozin & Metformin Hydrochloride (SR) Tablets | Each film coated bilayer Tablet contains: Linagliptin 5mg, Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg, Metformin Hydrochloride IP 500mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd. | 18.92 |
55 | Dapagliflozin, Vildagliptin (SR) and Metformin Hydrochloride (SR) tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg, Vildagliptin IP 100mg (as sustained release), Metformin Hydrochloride IP 1000mg (as sustained release) | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Blue Cross Laboratories Pvt. Ltd. | 11.70 |
56 | Empagliflozin + Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5mg Metformin Hydrochloride IP 850mg | 1 Tablet | M/s Mankind Pharma Limited | 11.51 |
57 | Empagliflozin+ Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5mg Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Mankind Pharma Limited | 11.38 |
58 | Empagliflozin+ Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5mg Metformin Hydrochloride IP 850mg | 1 Tablet | M/s Mankind Pharma Limited | 17.24 |
59 | Calcium carbonate + Magnesium Hydroxide + Zinc Sulphate + Vitamin D3 tablets | Each film coated tablet contains: Magnesium Hydroxide IP eq. to Elemental Magnesium 50mg, Vitamin D3 IP 1000IU, Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 10mg, Calcium Carbonate IP eq. to Elemental Calcium 500mg | 1 Tablet | M/s Unison Pharmaceuticals Pvt. Ltd. | 10.00 |
60 | Dapagliflozin + Metoprolol tablets | Each film coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg, Metoprolol Succinate IP 47.5mg eq. to Metoprolol Tartrate 50mg (as Sustained release) | 1 Tablet | M/s ERIS Lifesciences Limited | 16.77 |
S. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (in Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
61 | Montelukast + Bilastine tablets | Each film coated tablet contains: Montelukast Sodium IP Eq. to Montelukast 10mg, Bilastine IP 40mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Sun Pharma Laboratories Limited | 28.76 |
62 | Montelukast + Bilastine tablets | Each film coated tablet contains: Montelukast Sodium IP Eq. to Montelukast 10mg, Bilastine IP 40mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Sun Pharmaceutical Industries Limited | 28.76 |
The notification further added:
(a) The manufacturer of above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.
To view the official notice, click the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.